Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain

[1]  D. Zehnder,et al.  Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase , 2004, Molecular and Cellular Endocrinology.

[2]  H. Koeffler,et al.  Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells , 1996, Clinical & Experimental Metastasis.

[3]  W. Stumpf,et al.  1,25(OH)2 vitamin D3 sites of action in the brain , 1987, Histochemistry.

[4]  A. Mackay-Sim,et al.  Schizophrenia, vitamin D, and brain development. , 2004, International review of neurobiology.

[5]  D. Eyles,et al.  Vitamin D receptor expression in the embryonic rat brain , 2003 .

[6]  D. Eyles,et al.  1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons , 2003, Neuroscience Letters.

[7]  Aristides G. Eliopoulos,et al.  Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[8]  A. Mackay-Sim,et al.  Vitamin d3 and brain development , 2003, Neuroscience.

[9]  A. Mackay-Sim,et al.  The neurodevelopmental hypothesis of schizophrenia: a review of recent developments , 2003, Annals of medicine.

[10]  François Berger,et al.  New clues about vitamin D functions in the nervous system , 2002, Trends in Endocrinology & Metabolism.

[11]  J. McGrath,et al.  Vitamin D: the neglected neurosteroid? , 2001, Trends in Neurosciences.

[12]  G. Jirikowski,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  B. Hoffer,et al.  Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats , 2001, Brain Research.

[14]  G. Panzica,et al.  Steroids in the nervous system: a Pandora's box? , 2001, Trends in Neurosciences.

[15]  R. Kumar,et al.  Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. McGrath,et al.  Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders? , 2001, Medical hypotheses.

[17]  A. Howie,et al.  Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .

[18]  Philip W. Landfield,et al.  Vitamin D Hormone Confers Neuroprotection in Parallel with Downregulation of L-Type Calcium Channel Expression in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[19]  S. Kikuchi,et al.  Effect of 1,25‐dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L‐buthionine sulfoximine and 1‐methyl‐4‐phenylpyridine , 2000, Journal of neuroscience research.

[20]  T. Hayashi,et al.  Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats , 2000, Neuropharmacology.

[21]  M. Miller,et al.  A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats , 1999, Diabetologia.

[22]  F. Holsboer,et al.  Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives , 1999, Trends in Neurosciences.

[23]  W. Staines,et al.  Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  D. Zehnder,et al.  The renal function of 25-hydroxyvitamin D3-1α-hydroxylase , 1999, Molecular and Cellular Endocrinology.

[25]  T. Veenstra,et al.  Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.

[26]  H. DeLuca,et al.  Current understanding of the molecular actions of vitamin D. , 1998, Physiological reviews.

[27]  P. Brachet,et al.  1,25‐dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro , 1998 .

[28]  S. Brimijoin,et al.  1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo , 1998, Brain Research.

[29]  H. Zakon.  The effects of steroid hormones on electrical activity of excitable cells , 1998, Trends in Neurosciences.

[30]  P. Brachet,et al.  Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25‐dihydroxyvitamin D3 , 1998, Glia.

[31]  W. Miller,et al.  Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. , 1997, Molecular endocrinology.

[32]  G. Jirikowski,et al.  1.25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus. , 1997, Cellular and molecular biology.

[33]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. , 1997, Brain research. Molecular brain research.

[34]  J. Barsony,et al.  Subcellular Distribution of Normal and Mutant Vitamin D Receptors in Living Cells , 1997, The Journal of Biological Chemistry.

[35]  D. Feldman,et al.  Vitamin D in the nervous system: actions and therapeutic potential. , 1997 .

[36]  D. Feldman,et al.  1,25-Dihydroxyvitamin D3 Induction of Nerve Growth Factor in L929 Mouse Fibroblasts: Effect of Vitamin D Receptor Regulation and Potency of Vitamin D3 Analogs1. , 1997, Endocrinology.

[37]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3, an inducer of glial cell line‐derived neurotrophic factor , 1996, Neuroreport.

[38]  E. Stachowiak,et al.  Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. , 1996, Brain research. Molecular brain research.

[39]  S. Christakos,et al.  Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. , 1995, Molecular endocrinology.

[40]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3 regulates NT‐3, NT‐4 but not BDNF mRNA in astrocytes , 1994, Neuroreport.

[41]  P. Brachet,et al.  1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. , 1994, Brain research. Molecular brain research.

[42]  S. Carswell,et al.  Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain , 1994, Brain Research.

[43]  E. Ritz,et al.  1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. , 1993, Blood.

[44]  H. Bidmon,et al.  Vitamin d nuclear binding to neurons of the septal, substriatal and amygdaloid area in the siberian hamster (Phodopus sungorus) brain , 1992, Neuroscience.

[45]  M. Somerville,et al.  Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.

[46]  R. Houlgatte,et al.  1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis , 1991, Journal of neuroscience research.

[47]  K. Haglid,et al.  Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Haussler,et al.  Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.

[49]  H. DeLuca,et al.  Brain target sites for 1,25-dihydroxyvitamin D3. , 1982, Science.